Pfizer today announced that its board of directors declared a $0.43 fourth-quarter 2026 dividend on the company's common stock, payable December 7, 2026, to holders of the Common Stock of record at the close of business on November 6, 2026. The board of directors of Worthington
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.